These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of a novel azaspirane (SK&F 105685) on arthritic lesions in the adjuvant Lewis rat: attenuation of the inflammatory process and preservation of skeletal integrity. High WB; Bugelski PJ; Nichols ME; Swift BA; Solleveld HA; Badger AM J Rheumatol; 1994 Mar; 21(3):476-83. PubMed ID: 8006892 [TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610. Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285 [TBL] [Abstract][Full Text] [Related]
6. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane. Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808 [TBL] [Abstract][Full Text] [Related]
8. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs. Reasor MJ Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447 [TBL] [Abstract][Full Text] [Related]
9. Atiprimod (SK&F 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppressive in Candida-infected mice. Badger AM; Handler JA; Genell CA; Herzyk D; Gore E; Polsky R; Webb L; Bugelski PJ Int J Immunopharmacol; 1999 Mar; 21(3):161-76. PubMed ID: 10348366 [TBL] [Abstract][Full Text] [Related]
10. Effects of SK&F 105685, a novel anti-arthritic agent, on immune function in the dog. Kaplan JM; Badger AM; Ruggieri EV; Swift BA; Bugelski PJ Int J Immunopharmacol; 1993 Feb; 15(2):113-23. PubMed ID: 8468115 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes. Badger AM; Dimartino MJ; Talmadge JE; Picker DH; Schwartz DA; Dorman JW; Mirabelli CK; Hanna N Int J Immunopharmacol; 1989; 11(7):839-46. PubMed ID: 2532178 [TBL] [Abstract][Full Text] [Related]
12. Induction of non-specific suppressor cells in normal Lewis rats by a novel azaspirane SK&F 105685. Badger AM; King AG; Talmadge JE; Schwartz DA; Picker DH; Mirabelli CK; Hanna N J Autoimmun; 1990 Aug; 3(4):485-500. PubMed ID: 2145847 [TBL] [Abstract][Full Text] [Related]
13. Antiarthritic and suppressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents. Badger AM; Schwartz DA; Picker DH; Dorman JW; Bradley FC; Cheeseman EN; DiMartino MJ; Hanna N; Mirabelli CK J Med Chem; 1990 Nov; 33(11):2963-70. PubMed ID: 2146392 [TBL] [Abstract][Full Text] [Related]
14. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels. Heyneman CA; Reasor MJ J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400 [TBL] [Abstract][Full Text] [Related]
16. The effect of SK&F 105685, a novel suppressor cell-inducing compound, in the adjuvant arthritic rat. Badger AM; Swift BA; Bugelski PJ; High WB; DiMartino MJ; Greig R Br J Rheumatol; 1991; 30 Suppl 2():66-9. PubMed ID: 1825183 [No Abstract] [Full Text] [Related]
17. Therapeutic activity of SK&F 105685, a novel azaspirane with suppressor-cell inducing activity. Badger AM; Swift BA Clin Exp Rheumatol; 1993; 11 Suppl 8():S107-9. PubMed ID: 8324933 [TBL] [Abstract][Full Text] [Related]
18. Selective immunomodulatory activity of SK&F 106615, a macrophage-targeting antiarthritic compound, on antibody and cellular responses in rats and mice. Badger AM; Newman-Tarr TM; Satterfield JL Immunopharmacology; 1997 Aug; 37(1):53-61. PubMed ID: 9285244 [TBL] [Abstract][Full Text] [Related]
19. Induction of non-specific suppressor cells and myeloregulatory effects of an immunomodulatory azaspirane, SK&F 105685. King AG; Olivera D; Talmadge JE; Badger AM Int J Immunopharmacol; 1991; 13(1):91-100. PubMed ID: 1827431 [TBL] [Abstract][Full Text] [Related]